subject: Antares Pharma, Inc. (ais) Swot Profile---aarkstore Enterprise Market Research Aggregation [print this page] Summary Summary
Antares Pharma, Inc. (AIS) SWOT Profile is a comprehensive business, functional and strategic analysis of Antares Pharma, Inc.. The profile delves into the operations of the company to present an in-depth analysis of the various aspects related to its business. It analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, executive biographies and key competitors. The hallmark of the profile is the detailed strategic analysis of the company. This highlights and presents an unbiased view of its key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by understanding your partners, customers and competitors better.
Antares Pharma, Inc. (Antares Pharma) is a drug delivery company, engaged in the development and commercialization of novel therapeutic products using its advanced drug delivery systems including Advanced Transdermal Delivery (ATD) gels, disposable pressure assisted auto injection systems (Vibex), reusable needle-free injection systems (VISION), disposable pen injection systems and oral disintegrating (Easy Tec) tablets. The company principally operates in the US, and Europe.
Key Recent Developments
Mar 23, 2010: Antares Pharma Reports Net Loss Of $2.4 Million In Q4 2009
Jan 20, 2010: Antares Pharma Appoints Pavan Handa As Senior Vice President, Business Development
Jan 20, 2010: Antares Names Pavan Handa As Senior Vice President Of Business Development
Scope
- Examines key information about company for business intelligence.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented objectively. Business, strategic and operational aspects are taken into account.
- Opportunities available to the company are sized up and its growth potential assessed. Competitive and/or technological threats are highlighted.
- The profile contains valuable and critical company information business structure and operations, the company history, major products and services, prospects, key competitors, key employees, executive biographies, important locations and subsidiaries.
- The profile provides detailed financial ratios for the past five years as well as interim ratios for the last five interim periods for major public companies.
- Financial ratios presented for major public companies include revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
